High prevalence of microcytic anaemia in Omani children: a prospective study

A Padmanabhan1, S Thomas, H Sheth

  • 1Department of Child Health, Ibra Central Hospital, Ibra, PO Box 03, PC 413, Sultanate of Oman. padmnabn@omantel.net.om

Insights

In Oman, alpha-thalassaemia trait is a common cause of microcytic anemia in children, complicating iron deficiency diagnosis. This study highlights the need to consider hemoglobinopathies when diagnosing anemia in this region.

Area of Science:

  • Pediatrics
  • Hematology
  • Genetics

Background:

  • Iron deficiency is a primary cause of microcytic anemia.
  • Haemoglobinopathies, particularly alpha-thalassaemia, are prevalent in Arab populations, complicating anemia diagnosis.
  • Accurate diagnosis of anemia requires differentiating between iron deficiency and inherited hemoglobin disorders.

Purpose of the Study:

  • To determine the prevalence and causes of anemia in Omani children.
  • To investigate the role of alpha-thalassaemia trait in microcytic anemia within this population.
  • To assess diagnostic challenges in differentiating anemia causes in regions with high hemoglobinopathy prevalence.

Main Methods:

  • Prospective study of 256 children aged 3-12 years in Oman.
  • Assessment of anemia prevalence using World Health Organization (WHO) criteria.
  • Evaluation of red blood cell indices, serum ferritin levels, and glucose-6-phosphate dehydrogenase deficiency.

Main Results:

  • Anemia prevalence was 45.1% in 3-5 year olds and 37.9% in 10-12 year olds.
  • All anemic children exhibited low mean corpuscular hemoglobin, with 75% showing microcytosis.
  • Normal serum ferritin and lack of glucose-6-phosphate dehydrogenase deficiency suggested non-iron deficiency causes for microcytosis.

Conclusions:

  • The high prevalence of microcytosis and microcytic anemia in Omani children is likely due to the alpha-thalassaemia trait.
  • Alpha-thalassaemia trait significantly confounds the diagnosis of iron deficiency anemia in Oman.
  • This finding is crucial for countries with high alpha-thalassaemia gene prevalence to ensure accurate anemia diagnosis.